Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2005
03/30/2005EP1250132B1 Ibuprofen containing active agent preparation
03/30/2005EP1248597B1 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
03/30/2005EP1246692B1 Templating of uncharged solid particles by polymer multilayers
03/30/2005EP1237551B1 Pharmaceutical formulations containing zolmitriptan
03/30/2005EP1194140B1 Pharmaceutical composition containing fenofibrate and preparation method
03/30/2005EP1191926B1 New omeprazole and (s)-omeprazole formulation
03/30/2005EP1181035B1 Substantially oil-free cyclosporin compositions
03/30/2005EP1124570A4 Novel neuropilin/growth factor binding and uses thereof
03/30/2005EP1005324B1 Compositions for delivery of biological agents and methods for the preparation thereof
03/30/2005EP1001978B1 Angiotensin derivatives
03/30/2005EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders
03/30/2005EP0929232B1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
03/30/2005EP0922464B1 Quickly disintegrable compression-molded materials and process for producing the same
03/30/2005EP0804194B1 Use of retinoic acid receptor-agonists or ap-1 antagonists for the manufacture of a medicament for preventing proliferation of retinal pigment epithelium
03/30/2005EP0791056B1 Lipid-cleavage enzyme complex
03/30/2005EP0778771B1 Topical ketoconazole emulsions
03/30/2005EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof
03/30/2005CN1602326A Lipid-polymer-conjugates
03/30/2005CN1602206A Pharmaceutical compositions based on azetidine derivatives
03/30/2005CN1602205A Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
03/30/2005CN1602203A Use of gp130 activators in diabetic neuropathy
03/30/2005CN1602200A Plant extract active as an immunostimulating agent
03/30/2005CN1602189A Composition comprising cysteamine for improving lactation in dairy animals
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1602186A Prolonged release biodegradable microspheres and method for preparing same
03/30/2005CN1602158A Food or pet food composition containing plant extract for bone health
03/30/2005CN1600372A Medication carrier of perforating membrane peptide of bell protein
03/30/2005CN1600371A Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
03/30/2005CN1600295A Stable stored composite emulsion carrier in even dimension for hydrophilicity medication and preparation method
03/30/2005CN1600294A Micro bubble reagent in use for method of blood vessel embolism induced by ultrasonic and method of beauty culture of subtracting fat
03/30/2005CN1194761C Dissolvent specially for omepazole sodium injection
03/30/2005CN1194760C Method for preparing oil-dissolved nanometre structure lipid medicine
03/30/2005CN1194758C Vaginal lactobacillus medicant
03/30/2005CN1194704C Polyester with its main train having amino acid and contg. active drug, and its prepn. method
03/30/2005CN1194698C Puerarin injection and its prepn, process
03/30/2005CN1194684C Maltilate emulsion and preparation proless thereof
03/30/2005CN1194677C Long-acting tretnoin intraocular slowly-releasing system
03/30/2005CN1194672C Transdermal therapeutic system with a highly effective neuroleptic agent
03/30/2005CN1194671C Sheet-form adhesive preparation
03/30/2005CA2483743A1 Stable suspensions for medicinal dosages
03/29/2005US6872804 Glycopeptide for use in the prevention and treatment of bacterial infections
03/29/2005US6872723 Stabilized difloxacin injectable solution
03/29/2005US6872705 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
03/29/2005US6872701 Glycopeptide phosphonate derivatives
03/29/2005US6872700 Methods for glucagon suppression
03/29/2005US6872415 Sugar-free pharmaceutical products
03/29/2005US6872410 Edible chewing gum and process for preparing
03/29/2005US6872407 Extended release formulations of erythromycin derivatives
03/29/2005US6872393 Polyalkylene oxide-modified single chain polypeptides
03/29/2005US6872387 Mixing alginate salt, calcium carbonate, and d-gluconolactone, crosslinking to form hydrogel, and controlling shrinking/ swelling; for scaffolds for the support of cells; solid phase synthesis; organ/tissue engineering; osteoblasts
03/29/2005US6872386 Immunization of aquatic animals against infectious diseases
03/29/2005US6872384 Comprises anionic microgel for treatment of corneal wounds
03/29/2005US6872336 Spraying a solution wherein a poorly soluble drug is dissolved in a plasticizer, and an aqueous solution and/or water dispersion of a water-soluble polymer, from nozzle outlets simultaneously and separately.
03/29/2005US6872180 Device and process for quantifying bodies by means of ultrasound
03/29/2005CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate
03/29/2005CA2301732C Therapeutic combinations
03/29/2005CA2240541C Stabilisers for live vaccines
03/29/2005CA2182582C Compositions containing micronized nebivolol
03/29/2005CA2170772C Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
03/29/2005CA2099869C Particulates
03/29/2005CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate
03/24/2005WO2005026372A1 Polyethyleneglycol-modified lipid compounds and uses thereof
03/24/2005WO2005026325A2 Bivalent targeting of cell surfaces
03/24/2005WO2005026318A2 Methods and compositions for producing antigenic responses
03/24/2005WO2005026269A1 Microorganism coating components, coatings, and coated surfaces
03/24/2005WO2005026214A1 Polysaccharide pseudo-sponge
03/24/2005WO2005026195A1 Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis
03/24/2005WO2005026048A1 Porous silica having substance carried thereon
03/24/2005WO2005025623A2 Ef-24-factor vii conjugates
03/24/2005WO2005025597A1 Peptides that promote complement activation
03/24/2005WO2005025592A2 In vivo modulation of neuronal transport
03/24/2005WO2005025560A1 Ophthalmic composition
03/24/2005WO2005025552A2 Protein binding compounds
03/24/2005WO2005025551A2 Pharmaceutical products comprising bisphosphonates
03/24/2005WO2005025548A1 Topical preparations comprising a hydrophilic carrier and a silicone matrix
03/24/2005WO2005025546A1 Agent containing ergolin for transdermal application
03/24/2005WO2005025537A1 Formulations of anthraquinone derivatives
03/24/2005WO2005025518A2 Inhibition of inward sodium currents in cancer
03/24/2005WO2005025513A2 Guanidinium derivatives for improved cellular transport
03/24/2005WO2005025512A2 Cobalamin conjugates for anti-tumor therapy
03/24/2005WO2005025508A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
03/24/2005WO2005025501A2 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer
03/24/2005WO2005025500A2 Process for preparing water soluble diterpenes and their applications
03/24/2005WO2005025488A2 Methods for the controlled delivery of pharmacologically active compounds
03/24/2005WO2005012870A3 Improved aminodextran compositions and conjugates and methods of making and using them
03/24/2005WO2005000324A3 Colloidal silver composition having antimicrobial properties
03/24/2005WO2004112713A3 Drug polymer complexes
03/24/2005WO2004110497A3 Mitomycin conjugates cleavable by thiols
03/24/2005WO2004108747A3 Lectin conjugates
03/24/2005WO2004091528B1 Delivery systems of homogeneous thermoreversible alginate films
03/24/2005WO2004087648A3 Stabilized phenytoin containing composition
03/24/2005WO2004084839A3 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
03/24/2005WO2004082557A3 Package for and formulation of medicaments
03/24/2005WO2004080382A3 Novel compositions containing fentanyl
03/24/2005WO2004076644A3 A composition for delivering an agent to a target cell and uses thereof
03/24/2005WO2004075834A3 Stabilized pharmaceutical compositions of safingol and methods of using the same
03/24/2005WO2004073643A3 Estradiol metabolites for the treatment of pulmonary hypertension
03/24/2005WO2004068931A3 Amphiregulin antibodies and their use to treat cancer and psoriasis
03/24/2005WO2004064788A3 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
03/24/2005WO2004062588A3 Water-soluble polymeric bone-targeting drug delivery system
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 1712